A recent FiercePharma article discussed Moderna’s decision not to enforce its COVID-19 vaccine patents against other companies during the pandemic. Moderna’s president said the company is “quite studiously not asserting infringement” in a Wall Street Journal interview, noting that the company isn’t interested in decreasing the number of vaccines available in a pandemic.
Moderna Isn’t Enforcing COVID-19 Vaccine IP
The company is willing to license the technology behind its coronavirus vaccine.
Oct 15, 2020